Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents☆

M. Manning(University of Toledo Medical Center), Gilles Guillon(Centre National de la Recherche Scientifique), Bernard Mouillac(Centre National de la Recherche Scientifique), S. Stoev(Trakia University), Bice Chini(Neuroscience Institute), Thierry Durroux(Centre National de la Recherche Scientifique)
Progress in brain research
January 1, 2008
10.1016/s0079-6123(08)00437-8
Cited by 289

Related Papers

THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics
|Journal of Neuroendocrinology|2012|424
A New Population of Parvocellular Oxytocin Neurons Controlling Magnocellular Neuron Activity and Inflammatory Pain Processing
|Neuron|2016|395
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Pharmacologic Rescue of Impaired Cognitive Flexibility, Social Deficits, Increased Aggression, and Seizure Susceptibility in Oxytocin Receptor Null Mice: A Neurobehavioral Model of Autism
|Biological Psychiatry|2011|376